Houston 9-year-old with terminal cancer hopes to be sworn-in by 100 law enforcement agencies
Despite his terminal cancer, 9-year-old Devarjaye says he's working to fulfill his law enforcement dreams and be sworn-in by 100 agencies! He's got seven titles and more on the way.
Despite his terminal cancer, 9-year-old Devarjaye says he's working to fulfill his law enforcement dreams and be sworn-in by 100 agencies! He's got seven titles and more on the way.
WHO warns omicron variant fears may set off hoarding of COVID-19 vaccines
The World Health Organization has expressed concerns that rich countries spooked by the emergence of the omicron variant could step up hoarding of COVID-19 vaccines.
The World Health Organization has expressed concerns that rich countries spooked by the emergence of the omicron variant could step up hoarding of COVID-19 vaccines.
Pfizer COVID booster: FDA expands extra dose to people as young as age 16
The Food and Drug Administration has given emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech -- if it's been six months since their last shot.
The Food and Drug Administration has given emergency authorization for 16- and 17-year-olds to get a third dose of the vaccine made by Pfizer and its partner BioNTech -- if it's been six months since their last shot.
Senate rejects Biden administration's COVID-19 vaccine mandate for businesses
The Senate has narrowly approved a resolution to nullify the Biden administration’s requirement that businesses with 100 or more workers have their employees be vaccinated against the coronavirus or submit to weekly testing.
The Senate has narrowly approved a resolution to nullify the Biden administration’s requirement that businesses with 100 or more workers have their employees be vaccinated against the coronavirus or submit to weekly testing.
Medicago's plant-based COVID-19 vaccine showing promising trial results, company says
Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant.
Medicago announced Tuesday that its two-dose vaccine was 71% effective at preventing COVID-19 infection in a large, late-stage study that included several variants including the delta variant.
Texas cheerleader breaks neck doing backflip yet spreads cheer from her wheelchair
Despite her slim chances of walking again, a north Texas cheerleader who was paralyzed while performing a backflip, maintains a positive attitude and continues to spread cheer.
Despite her slim chances of walking again, a north Texas cheerleader who was paralyzed while performing a backflip, maintains a positive attitude and continues to spread cheer.
Pfizer: COVID-19 booster offers protection against omicron in early study
Pfizer said its COVID-19 booster dose may protect against the new omicron variant, but the initial two doses appear significantly less effective.
Pfizer said its COVID-19 booster dose may protect against the new omicron variant, but the initial two doses appear significantly less effective.
COVID-related stress weighs heavily on Gen Z
Among Americans in Gen Z, 46% said the pandemic has made it harder to pursue their education or career goals.
Among Americans in Gen Z, 46% said the pandemic has made it harder to pursue their education or career goals.
WHO advises against use of COVID-19 survivors' plasma to treat patients battling virus
Experts at the World Health Organization recommended Tuesday against using blood plasma from people who have recovered from COVID-19.
Experts at the World Health Organization recommended Tuesday against using blood plasma from people who have recovered from COVID-19.
WHO: Kids in 5-14 age group account for Europe's highest COVID-19 rates
The WHO's office for Europe said children in the 5 to 14 age group now account for the highest rates of reported COVID-19 infections in the region.
The WHO's office for Europe said children in the 5 to 14 age group now account for the highest rates of reported COVID-19 infections in the region.
New international travel restrictions now in place as US officials try to curb spread of Omicron variant
U.S. health officials say early reports about Omicron are “encouraging” suggesting the new COVID-19 variant is less dangerous than Delta.
U.S. health officials say early reports about Omicron are “encouraging” suggesting the new COVID-19 variant is less dangerous than Delta.
Unvaccinated Illinois residents to pay own COVID-19 hospital bill, state lawmaker proposes
State Rep. Jonathan Carroll is proposing that any Illinois resident who refuses to get the COVID-19 vaccine should pay their own bill if hospitalized with the virus.
State Rep. Jonathan Carroll is proposing that any Illinois resident who refuses to get the COVID-19 vaccine should pay their own bill if hospitalized with the virus.
US to boost COVID-19 vaccine global distribution with $400M investment
“This money will speed efforts both to get shots in arms and to support vaccine manufacturing in low-and-middle-income countries,” USAID administrator Samantha Power announced Monday.
“This money will speed efforts both to get shots in arms and to support vaccine manufacturing in low-and-middle-income countries,” USAID administrator Samantha Power announced Monday.
NYC announces new vaccine mandate for all private sector employers
Beginning Dec. 27, all private-sector employers in New York City must require that their employees be fully vaccinated for the coronavirus, announced Mayor Bill de Blasio.
Beginning Dec. 27, all private-sector employers in New York City must require that their employees be fully vaccinated for the coronavirus, announced Mayor Bill de Blasio.
Oxford scientist behind COVID-19 vaccine says next pandemic may be worse
Professor Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that more money needs to be devoted to research and preparations.
Professor Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that more money needs to be devoted to research and preparations.
Omicron variant: Pfizer running ‘neutralization tests’ with its COVID-19 vaccine
Companies Pfizer and BioNTech are currently running tests in response to the rapidly spreading omicron variant with data likely available in the coming weeks.
Companies Pfizer and BioNTech are currently running tests in response to the rapidly spreading omicron variant with data likely available in the coming weeks.
Preview of ‘a post-Roe world’ in Texas over abortion access
Texas offers a glimpse in real time of what would be a striking new national landscape if the Supreme Court drastically curtails abortion rights: GOP-led states allowing almost no access to abortion, and women traveling hundreds of miles to end their pregnancies.
Texas offers a glimpse in real time of what would be a striking new national landscape if the Supreme Court drastically curtails abortion rights: GOP-led states allowing almost no access to abortion, and women traveling hundreds of miles to end their pregnancies.
Long-term COVID-19 smell, taste loss could impact millions, researchers say
As COVID-19 continues to spread, researchers say a significant number of people worldwide may face a long-term or even permanent loss of smell and taste as more become infected.
As COVID-19 continues to spread, researchers say a significant number of people worldwide may face a long-term or even permanent loss of smell and taste as more become infected.
Israel health officials confirm 7 omicron COVID-19 cases, 27 others suspected
Israel's Health Ministry says it has confirmed seven cases of the new omicron variant of the coronavirus, stoking fears of a pending surge in infections.
Israel's Health Ministry says it has confirmed seven cases of the new omicron variant of the coronavirus, stoking fears of a pending surge in infections.
FDA expands emergency use of 2 COVID-19 monoclonal antibody treatments to infants
Monoclonal antibodies are proteins made in a lab which copy the human immune system’s ability to fight off harmful pathogens such as the novel coronavirus, according to the U.S. Food and Drug Administration.
Monoclonal antibodies are proteins made in a lab which copy the human immune system’s ability to fight off harmful pathogens such as the novel coronavirus, according to the U.S. Food and Drug Administration.